Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
65
MKKGY Quote, Financials, Valuation and Earnings
Last price:
$30.42
Seasonality move
:
3.39%
Day range:
$29.66 - $29.88
52-week range:
$24.32 - $31.00
Dividend yield:
1.67%
P/E ratio:
19.81x
P/S ratio:
2.76x
P/B ratio:
6.42x
Volume:
62.7K
Avg. volume:
67.1K
1-year change:
4.73%
Market cap:
$64.9B
Revenue:
$22.9B
EPS (TTM):
$1.51
Analysts' Opinion
-
Consensus RatingMerck KGaA has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $34.04, Merck KGaA has an estimated upside of 13.96% from its current price of $29.87.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $34.00 representing 100% downside risk from its current price of $29.87.
Fair Value
-
According to the consensus of 1 analyst, Merck KGaA has 13.96% upside to fair value with a price target of $34.04 per share.
MKKGY vs. S&P 500
-
Over the past 5 trading days, Merck KGaA has underperformed the S&P 500 by -1.15% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Merck KGaA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Merck KGaA has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Merck KGaA reported revenues of $6.2B.
Earnings Growth
-
Merck KGaA has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Merck KGaA reported earnings per share of $0.48.
Enterprise value:
76.6B
EV / Invested capital:
--
Price / LTM sales:
2.76x
EV / EBIT:
15.41x
EV / Revenue:
3.26x
PEG ratio (5yr expected):
1.64x
EV / Free cash flow:
207.33x
Price / Operating cash flow:
175.78x
Enterprise value / EBITDA:
10.78x
Gross Profit (TTM):
$13.8B
Return On Assets:
5.89%
Net Income Margin (TTM):
13.96%
Return On Equity:
10.11%
Return On Invested Capital:
7.45%
Operating Margin:
22.9%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $22.8B | $22.7B | $23.5B | $5.8B | $6.2B | |
| Gross Profit | $13.7B | $13.3B | $13.8B | $3.5B | $3.8B | |
| Operating Income | $5B | $4.7B | $5B | $1.4B | $1.4B | |
| EBITDA | $7B | $7B | $7.1B | $1.9B | $2B | |
| Diluted EPS | $1.42 | $1.35 | $1.51 | $0.41 | $0.48 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $12B | $12.7B | $14.4B | $15.5B | $15.1B | |
| Total Assets | $50.8B | $49.9B | $52.8B | $56B | $59.8B | |
| Current Liabilities | $11.3B | $9.2B | $9.2B | $11.7B | $10.1B | |
| Total Liabilities | $26.8B | $22.1B | $22.9B | $24.3B | $25.8B | |
| Total Equity | $24B | $27.8B | $30B | $31.7B | $34.1B | |
| Total Debt | $9.5B | $9.1B | $10.1B | $8.8B | $12.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $4B | $4.7B | $4.3B | $1.6B | $1.8B | |
| Cash From Investing | -$1.8B | -$3.1B | -$4.8B | -$1.8B | -$3.5B | |
| Cash From Financing | -$1.3B | -$752.7M | -$409.7M | $787.3M | $3B | |
| Free Cash Flow | -$1.6B | $577.7M | $369.4M | -$646.5M | $579.3M | |
MKKGY
Sector
Market Cap
$64.9B
$25.8M
Price % of 52-Week High
96.36%
50.24%
Dividend Yield
1.67%
0%
Shareholder Yield
0.97%
-1.64%
1-Year Price Total Return
4.73%
-18.88%
Beta (5-Year)
0.973
0.496
Dividend yield:
1.67%
Annualized payout:
$0.47
Payout ratio:
-36.39%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$30.06
200-day SMA
Buy
Level
$27.06
Bollinger Bands (100)
Buy
Level
26.57 - 29.73
Chaikin Money Flow
Buy
Level
8.4M
20-day SMA
Buy
Level
$29.80
Relative Strength Index (RSI14)
Buy
Level
51.25
ADX Line
Sell
Level
10.27
Williams %R
Neutral
Level
-37.0862
50-day SMA
Buy
Level
$29.49
MACD (12, 26)
Buy
Level
0.13
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
5.5M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.9963)
Buy
CA Score
(Annual)
Level (0.3628)
Buy
Beneish M-Score
(Annual)
Level (-2.7171)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-1.9974)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.
Stock Forecast FAQ
In the current month, MKKGY has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MKKGY average analyst price target in the past 3 months is $34.04.
-
Where Will Merck KGaA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Merck KGaA share price will rise to $34.04 per share over the next 12 months.
-
What Do Analysts Say About Merck KGaA?
Analysts are divided on their view about Merck KGaA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Merck KGaA is a Sell and believe this share price will drop from its current level to $34.00.
-
What Is Merck KGaA's Price Target?
The price target for Merck KGaA over the next 1-year time period is forecast to be $34.04 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MKKGY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Merck KGaA is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of MKKGY?
You can purchase shares of Merck KGaA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Merck KGaA shares.
-
What Is The Merck KGaA Share Price Today?
Merck KGaA was last trading at $30.42 per share. This represents the most recent stock quote for Merck KGaA. Yesterday, Merck KGaA closed at $29.87 per share.
-
How To Buy Merck KGaA Stock Online?
In order to purchase Merck KGaA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get MKKGY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MKKGY
Sector
P/E ratio
19.81x
23.44x
PEG ratio
1.64x
-0.01x
P/B ratio
6.42x
1.81x
Price / LTM sales
2.76x
1.56x
Growth Metrics
MKKGY
Sector
Revenue growth
7.42%
3.27%
Earnings growth
18.62%
9.66%
Revenue (5-year growth)
4.83%
6.43%
Earnings forecast
$0.49
-$0.20
Profitability
MKKGY
Sector
Profitability FY 2024
$12.9B
$2.3M
Return on invested capital
7.45%
-33.49%
Return on assets
5.89%
-29.74%
Return on equity
10.11%
-39.33%
Earnings Date
Last Earnings Date
Nov
13
Next Earnings Date
Mar
5
Estimated Next Earnings Date
Feb
12
Balance Sheet
MKKGY
Sector
Total cash
$2.6B
$24.2M
Short term investments
$580.6M
$23.8M
Total assets
$53.9B
$71.1M
Long term debt
$12.3B
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 38x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
37
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
59
SEZL alert for Feb 27
Sezzle, Inc. [SEZL] is down 13.92% over the past day.
Buy
83
GCT alert for Feb 27
GigaCloud Technology, Inc. [GCT] is down 5.87% over the past day.
Buy
62
LMAT alert for Feb 27
LeMaitre Vascular, Inc. [LMAT] is down 4.76% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
